A technical primer on the bioelectromagnetic and optical engineering principles behind our instruments — traceable in every detail to Dr. Royal Raymond Rife's published documentation and the modern peer-reviewed research that has independently studied the underlying mechanisms.
Living tissue both produces and responds to electromagnetic signals at specific frequencies. This is not theory — it is settled mainstream science (see magnetoencephalography, PEMF, electrical stimulation for wound healing). Our instruments are precision research tools for engaging that principle in a controlled way.
A precision oscillator produces a stable radio-frequency carrier signal at controlled amplitude.
The carrier is amplitude-modulated at lower target frequencies, the parameter set under investigation.
The modulated signal is delivered via a calibrated emitter — the design lineage Dr. Rife established with his original devices.
Frequency-specific cellular pathways respond per the published bioelectromagnetic literature (Pilla, Funk & Monsees, Adey, Zimmerman et al.).
Each step in this pipeline is documented in the Research Archive.
Every design decision in our instruments traces to documented engineering — either Dr. Rife's own published specifications, his collaborators' work, or modern peer-reviewed validation of related principles.
Our instruments deliver amplitude-modulated radio-frequency signals at user-selectable target frequencies. The target-frequency concept — that distinct biological systems respond to distinct electromagnetic frequencies — is the principle Dr. Rife pioneered in his laboratory and which modern peer-reviewed research has independently confirmed (Zimmerman et al., Chinese Journal of Cancer, 2013).
We do not pre-program "treatment frequencies" into our instruments. We provide the precision oscillator and modulator; what frequencies the user investigates is theirs to choose, document, and report.
Frequency-specific cellular response is settled bioelectromagnetics science — see Pilla 2013, Funk & Monsees 2006, Adey 1981 in the Research Archive.
Our radio-frequency carrier centers on 27.12 MHz — the same carrier used by the Zimmerman et al. 2013 peer-reviewed cancer-frequency research, and a frequency in the international Industrial, Scientific, and Medical (ISM) band reserved for non-communications uses worldwide.
Carrier choice is engineering, not magic: the ISM band is the legitimately-allocated frequency space for instruments of this class. Operating in-band keeps our instruments compliant with FCC regulations and aligned with the carrier characteristics of the modern peer-reviewed research.
The 27.12 MHz ISM allocation is also used by FDA-cleared medical-electrosurgical and short-wave diathermy devices.
The output stage and emitter geometry of our instruments derive from the engineering documentation Dr. Rife and his direct collaborators developed and refined. Specifically, the work captured in the Rife–Crane–Holman–Dorneanu engineering compendium provides the verified original-source specifications for emitter construction, calibration, and signal-fidelity verification.
This is the design lineage. It does not include any of the post-1971 derivative "Rife machine" frequency-list configurations from third parties, which are not part of the documented original engineering record.
Original-source engineering documents are catalogued in our internal research archive and inform every build specification.
Each instrument is hand-assembled by Matthew Rife in the Philadelphia workshop and individually calibrated against reference standards before shipment. A signed calibration certificate ships with every instrument, recording the verified operating parameters as measured at delivery.
This is not artisanal positioning — it is a function of the precision the instruments require. Frequency stability, modulation fidelity, and output power are each measured, documented, and signed off by hand because those are the parameters that distinguish a research-grade instrument from a hobby toy.
Calibration reference standards traceable to NIST.
A representative specification for our base research instrument. Specific configurations (custom emitter geometries, extended frequency ranges, integration interfaces) are available on request.
| Carrier Frequency | 27.12 MHz ± 0.001% (ISM band, crystal-stabilized) |
| Amplitude Modulation Range | 0.01 Hz to 50 kHz, user-selectable, 0.01 Hz resolution |
| Output Power | Calibrated low-level non-thermal range, configurable |
| Frequency Stability | Crystal-referenced, drift < 5 ppm over operating temperature range |
| Construction | Hand-assembled, point-to-point on critical signal paths |
| Calibration | Individually verified against NIST-traceable reference standards; signed certificate ships with each unit |
| Documentation | Full schematic + calibration record + use guide included |
| Warranty | One-year manufacturer warranty against defects in materials and workmanship |
Detailed specifications and technical drawings are released to verified customers on inquiry.
It is settled mainstream science that biological tissue produces and responds to electromagnetic fields at specific frequencies. Three quotations from the published peer-reviewed record establish the principle.
Tumor-specific modulation frequencies regulate the expression of genes involved in migration and invasion and disrupt the mitotic spindle — demonstrating the ability of tumor-specific frequencies to block growth of tumor cells in a tissue- and tumor-specific fashion.Chinese Journal of Cancer · 2013 · Peer-reviewed Zimmerman et al. — Modern in-vitro confirmation of frequency-specific cellular response
Non-thermal electromagnetic fields act as first messengers in cellular signaling cascades. Field characteristics — frequency, waveform, amplitude — determine which biological pathways respond. The mechanistic basis for "frequency specificity" is now well established at the cellular biology level.Electromagnetic Biology and Medicine · 2013 · Peer-reviewed Pilla, A. A. — Mechanism review on non-thermal EM field cellular signaling
Specific narrow frequency ranges — biological "windows" — produce measurable cellular effects, outside of which no effect is observed. This window-effect phenomenon is the cell-biology basis of frequency-specific therapy.Physiological Reviews · 1981 · Peer-reviewed (American Physiological Society) Adey, W. R. — Foundational review establishing biological window effects
Our instruments are precision research-grade signal generators. They are not medical devices, are not marketed for any specific medical condition, and we do not provide treatment recommendations.
We make our customers no clinical promises. We provide an instrument built to documented specifications, sourced to documented engineering lineage, and supported by a transparent literature archive. What customers do with that instrument — within applicable laws and their own professional judgment — is theirs.
If you require a medical device for a specific condition, consult a qualified healthcare professional and pursue an FDA-cleared product appropriate to that need.